Menu
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Everywhere
Threads
This forum
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Info Obat dan Regulator Obat Dunia
Prev
1
…
Go to page
Go
59
60
61
62
63
…
Go to page
Go
126
Next
First
Prev
61 of 126
Go to page
Go
Next
Last
Filters
Show only:
Loading…
F
FDA Compounding Quality Center of Excellence Cross-Sector Stakeholder Group
FDA
Oct 25, 2022
Replies
0
Views
550
Oct 25, 2022
FDA
F
F
Physicochemical and Structural (Q3) Characterization of Topical Drug Products Submitted in ANDAs
FDA
Oct 23, 2022
Replies
0
Views
680
Oct 23, 2022
FDA
F
F
In Vitro Permeation Test Studies for Topical Drug Products Submitted in ANDAs
FDA
Oct 23, 2022
Replies
0
Views
583
Oct 23, 2022
FDA
F
F
Topical Dermatologic Corticosteroids: In Vivo Bioequivalence
FDA
Oct 23, 2022
Replies
0
Views
621
Oct 23, 2022
FDA
F
F
IND Submissions for Individualized Antisense Oligonucleotide Drug Products for Severely Debilitating or Life-Threatening Diseases: Clinical Recommenda
FDA
Oct 23, 2022
Replies
0
Views
598
Oct 23, 2022
FDA
F
F
FDA issues final guidance about multiple endpoints in clinical trials
FDA
Oct 23, 2022
Replies
0
Views
590
Oct 23, 2022
FDA
F
F
In Vitro Release Test Studies for Topical Drug Products Submitted in ANDAs
FDA
Oct 23, 2022
Replies
0
Views
564
Oct 23, 2022
FDA
F
E
EMA recommends approval of second adapted Spikevax vaccine, CHMP, 19/10/2022
EMA
Oct 21, 2022
Replies
0
Views
584
Oct 21, 2022
EMA
E
E
EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age, CHMP, 19/10/2022
EMA
Oct 21, 2022
Replies
0
Views
566
Oct 21, 2022
EMA
E
F
Multiple Endpoints in Clinical Trials Guidance for Industry
FDA
Oct 20, 2022
Replies
0
Views
571
Oct 20, 2022
FDA
F
F
Guidance Recap Podcast | Multiple Endpoints in Clinical Trials
FDA
Oct 20, 2022
Replies
0
Views
541
Oct 20, 2022
FDA
F
F
FDA Clinical Investigator Training Course (CITC) 2022 - 12/07/2022
FDA
Oct 20, 2022
Replies
0
Views
587
Oct 20, 2022
FDA
F
F
GDUFA User Fee Rates Archive
FDA
Oct 20, 2022
Replies
0
Views
596
Oct 20, 2022
FDA
F
F
Advancing Real-World Evidence Program
FDA
Oct 20, 2022
Replies
0
Views
552
Oct 20, 2022
FDA
F
F
Acute Myeloid Leukemia: Developing Drugs and Biological Products for Treatment
FDA
Oct 18, 2022
Replies
0
Views
571
Oct 18, 2022
FDA
F
F
FDA NanoDay Symposium 2022 - 10/11/2022
FDA
Oct 18, 2022
Replies
0
Views
581
Oct 18, 2022
FDA
F
F
CDER’s Framework for Regulatory Advanced Manufacturing Evaluation (FRAME) Initiative
FDA
Oct 18, 2022
Replies
0
Views
694
Oct 18, 2022
FDA
F
F
Tissue Agnostic Drug Development in Oncology
FDA
Oct 18, 2022
Replies
0
Views
637
Oct 18, 2022
FDA
F
F
Characterizing, Collecting, and Reporting Immune-Mediated Adverse Reactions in Cancer Immunotherapeutic Clinical Trials
FDA
Oct 18, 2022
Replies
0
Views
565
Oct 18, 2022
FDA
F
F
Remarks by FDA Commissioner Robert M. Califf to the 2022 NORD Breakthrough Summit - 10/17/2022
FDA
Oct 18, 2022
Replies
0
Views
626
Oct 18, 2022
FDA
F
Prev
1
…
Go to page
Go
59
60
61
62
63
…
Go to page
Go
126
Next
First
Prev
61 of 126
Go to page
Go
Next
Last
You must log in or register to post here.
Home
Forums
Forum Diskusi Untuk Umum
Isu Terkini Seputar Farmakologi
Top